Therapeutic Advances in Immune Thrombocytopenia: Patient-Centric Paths to Improving Long-Term Outcomes

Published Date: 12 May 2026

Read Full News

Latest News

Nothing to Shrug About: Shoulder Reproducibility with SGRT

A pilot study suggests open-face SGRT immobilization is feasible for HN radiotherapy, with shoulder reproducibility similar to conventional masks.

Paget's Disease Mimicking Metastasis: A Diagnostic Pitfall

A case of rising PSA and widespread sclerotic bone lesions turned out to be Paget's disease, not metastasis—avoiding unnecessary ADT and bone harm.

Efficacy of Lu177-PSMA in Pretreated Older Veterans

Lutetium177-PSMA-617 is a radioligand therapy for PSMA-positive metastatic castrate resistant prostate cancer after receipt of at least 1 ARPI.

Care Coordination for Evaluation of Possible Malignancy

VHA Directive 1415 mandates that all VA systems implement formal, documented processes with clear roles to manage suspected cancer cases.

S1 Episode 2: Seeing Gout Clearly: Advances in Diagnosis and Imaging

Drs Kenneth Saag and Nicola Dalbeth explore how crystal analysis and imaging advances can sharpen gout diagnosis and guide patient care.

Common Causes of Vertigo in Primary Care: Part 3

Clinicians should be prepared to identify vestibular migraine, the rare Ménière disease, and persistent postural perceptual dizziness, a functional disorder.

Todays Updates

Sevabertinib Approved for First-Line Mutated NSCLC

The oral HER2 TKI was previously given accelerated approval in the second line for the indication.

Todays Updates

Sevabertinib Approved for First-Line Mutated NSCLC

The oral HER2 TKI was previously given accelerated approval in the second line for the indication.

Latest News

A pilot study suggests open-face SGRT immobilization is feasible for HN radiotherapy, with shoulder reproducibility similar to conventional masks.

A case of rising PSA and widespread sclerotic bone lesions turned out to be Paget's disease, not metastasis—avoiding unnecessary ADT and bone harm.

Lutetium177-PSMA-617 is a radioligand therapy for PSMA-positive metastatic castrate resistant prostate cancer after receipt of at least 1 ARPI.

VHA Directive 1415 mandates that all VA systems implement formal, documented processes with clear roles to manage suspected cancer cases.

Drs Kenneth Saag and Nicola Dalbeth explore how crystal analysis and imaging advances can sharpen gout diagnosis and guide patient care.

Clinicians should be prepared to identify vestibular migraine, the rare Ménière disease, and persistent postural perceptual dizziness, a functional disorder.

News All Time

The Looming 100-Million Cancer Workforce Crisis

Global workforce inequities are widening the cancer survival gap. Prof David Kerr highlights the stark realities and calls for an improved training approach.

Are Smart Glasses the Future of Collaborative Surgery?

Orthopedic surgeon Amgad Nakhla is using smart glasses in theater to bring remote expertise into com-plex cases and support real-time decisions.

Thyroid: A Year in Review

Drs Kaniksha Desai and Anupam Kotwal discuss thyroid: a year in review.

Fast Five Quiz: PPF Management

What do you know about the management for progressive pulmonary fibrosis? Test your knowledge with this quick quiz.

CT Radiation Risk: Is it Time to Rethink Imaging?

Two high-impact studies link routine CT scans to significant lifetime cancer risks. Dr Maurie Markman discusses why we can no longer ignore the data.

Preview: New Thyroid Nodule Guidelines

Drs Kaniksha Desai and Victor Bernet discuss the new guidelines for thyroid nodules.

Migraine and Stroke: What's the Real Risk?

Neurologist Indu Subramanian and migraine expert Andrew Charles discuss the risk for stroke in patients with migraine.

De-Escalated Treatment for Early Breast Cancer Continues to Gain Momentum

More patients of all ages skip sentinel lymph node biopsy, get less aggressive RT or none at all

Creeping Gradients After TAVR Linked to Poor Longer-Term Outcomes

Registry tracked incidence, prognostic impact of early hemodynamic valve deterioration

Pancreatic Cancer Risk Much Higher for Certain Group, Study Suggests

Long-term follow-up of low-risk pancreatic cystic lesions may be necessary

Tile-Based Radiation Tops Standard for Resected Brain Metastases

Approach significantly improved local control, and longer survival observed in trial

Trump's Doc Says President Is in 'Excellent Health' as BMI Approaches Obesity Range

Report shows Trump has a BMI of 29.7 and was given advice on diet and physical activity

ASNR Expert Video Roundtable: Expert Video Rountable from the American Society of Neuroradiology

Breakthroughs in Gastrointestinal Cancers From ASCO 2026

Breakthroughs in pancreatic cancer, novel drug combinations, and the role of observation in colorectal cancer are among the advances in gastrointestinal cancer at ASCO 2026 selected by Dr Manish Shah.

Jun 19 2026 This Week in Cardiology

Listener feedback, more long-term data on the TAVR/SAVR question, population prevalence of valvular heart disease in the US, and a CMS proposal to expand TAVR coverage are the topics John Mandrola, MD, discusses in this week’s podcast.